ea0016p322 | Endocrine tumours | ECE2008
Dardano Angela
, Ballardin Michela
, Traino Claudio
, Caraccio Nadia
, Colato Chiara
, Barale Roberto
, Mariani Giuliano
, Ferdeghini Marco
, Monzani Fabio
Background: Radioiodine (131I) therapy is performed in patients with differentiated thyroid cancer (DTC), either for thyroid remnant ablation or treating distant metastasis. Although 131I therapy is generally considered safe, a genotoxic damage has been demonstrated both in vivo and in vitro.Aim: To evaluate the possible effect of Ginkgo biloba extract (EGb 761) supplementation on the time-course (up to 1...